EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Neurofilaments: A Promising Diagnostic and Prognostic Biomarker in Multiple Sclerosis

Deepali Mathur iD, Shivangi Vikas Mishra, Soumyashree Rout, Ramesh Kandimalla, Francisco José López-Iranzo, Gerardo López-Rodas iD, Rohin Vinayak iD, Bonaventura Casanova, Bikash Kumar Mishra

Annals of Neurosciences · 20.04.2026

DOI: 10.1177/09727531261421804 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of Neurosciences, online erschienen am 20.04.2026. Verfasst von Deepali Mathur und 8 weiteren Autor:innen. Beteiligte Einrichtung: Neuro Care Centre, Bhubaneswar, Odisha, India. Die Arbeit nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Axonal damage results in permanent cognitive and physical disability during the early as well as progressive stages of multiple sclerosis (MS). However, the mechanism of axonal damage may vary during different stages of MS. The extent and severity of the disease can be estimated by various clinical tests and imaging. However, these measures lack sensitivity and accuracy for understanding subclinical disease activity. Therefore, there is a need for a promising biomarker that can reflect on clinical and subclinical disease activities and have additional diagnostic applications, such as studying MS pathology, disease severity, and rate of relapse. Summary Neurofilaments (NFs) are released into the extracellular fluid following axonal insult, and hence, measuring them can help understand the severity of neuro-axonal damage, particularly during early stages of the disease. It can, therefore, serve as a promising biomarker in MS. Key Message This review discusses NFs’ biology and its correlation with disease activity, which may have clinical applicability in the diagnosis and prognosis of MS. Furthermore, their levels in response to treatment are also discussed, which can assist in the development of therapeutic strategies.

Schlagwörter

Stichwörter der Autor:innen

Axonal damagebiomarkerdiagnosis and prognosismultiple sclerosisneurofilaments

Autor:innen und Institutionen

  • Neuro Care Centre, Bhubaneswar, Odisha, India.
  • Deepali Mathur and Shivangi Vikas Mishra are equivalent first authors.
  • IMS and SUM Hospital, Bhubaneswar, Odisha, India.
  • Department of Biochemistry, Kakatiya Medical College, Warangal, Telangana, India.
  • Department of Applied Biology, Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad, Telangana, India.
  • Hospital of Requena, Generalitat Valenciana, Spain.

ORCID-Profile: Deepali Mathur, Gerardo López-Rodas, Rohin Vinayak

Zitieren

APA

Mathur, D., Mishra, S. V., Rout, S., Kandimalla, R., López-Iranzo, F. J., López-Rodas, G., Vinayak, R., Casanova, B., & Mishra, B. K. (2026). Neurofilaments: A Promising Diagnostic and Prognostic Biomarker in Multiple Sclerosis. Annals of Neurosciences. https://doi.org/10.1177/09727531261421804

Vancouver

Mathur D, Mishra SV, Rout S, Kandimalla R, López-Iranzo FJ, López-Rodas G, et al. Neurofilaments: A Promising Diagnostic and Prognostic Biomarker in Multiple Sclerosis. Annals of Neurosciences. 2026. doi:10.1177/09727531261421804

BibTeX
@article{Mathur2026,
  author = {Mathur, Deepali and Mishra, Shivangi Vikas and Rout, Soumyashree and Kandimalla, Ramesh and López-Iranzo, Francisco José and López-Rodas, Gerardo and Vinayak, Rohin and Casanova, Bonaventura and Mishra, Bikash Kumar},
  title = {Neurofilaments: A Promising Diagnostic and Prognostic Biomarker in Multiple Sclerosis},
  journal = {Annals of Neurosciences},
  year = {2026},
  doi = {10.1177/09727531261421804}
}
Kostenlos starten →